BioMarin Pharmaceutical Inc. (BMRN) Social Stream



BioMarin Pharmaceutical Inc. (BMRN): $76.93

1.42 (+1.88%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BMRN to Watchlist
Sign Up

Industry: Biotech


Ranked

of 493

in industry

Featured Post From StockTwits About BMRN

$BMRN $XBI $BBH $XLV $BBH vol drying up on down take in the last weeks. Never seen an area so worked over like squeezing blood out of a turnip. I’ve been doing this along time . Only remaining retail traders selling now and they are drying up. Over the past 30 years of trading Ive made the most $$$ actually buying at these entries. Takes patience!
Top_Dog_Pro_Trader, published May 10, 2021

What Else are BMRN Traders Talking About?


Other tickers frequently mentioned alongside BMRN are XBI, BBH and XLV.

Other Notable StockTweets About BMRN


$BMRN STRONG BUY -
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Biomarin Pharmaceutical Inc.
BY MT Newswires
— 11:15 AM ET 04/30/2021
We maintain our target price at $117 based on our net present value analysis. Q1 product sales decreased to $468 million from $489 million in the prior-year period, exceeding expectations. The company announced that its expected FDA action date for Voxzogo (vosoritide for achondroplasia) was extended by three months to November 20 so that regulators can review recently submitted 2-year Phase 3 results, pushing back potential U.S. launch of Voxzogo to late 2021 or early 2022. In Europe, Voxzogo remains on-track for a Q3 launch. We are confident in the potential launch of Voxzogo based on the drug's profile and well-defined patient population. Meanwhile, Roctavian seems to be on-track for U.S. and E.U. launches in the second half of 2022.

dloeb, published April 30, 2021

$BMRN is a name not talked about alot. Been watching this inverted HnS form up under trend res & in range.

See if this can get going in the coming weeks.

This is play of nit picky entries with patience. Commons or longer out contracts.

Ultimately I believe it to pay!

dafster17, published April 26, 2021

$BMRN received the email: “BioMarin Pharmaceutical Inc.'s Annual Meeting is on 5/25/2021. As an investor in BioMarin Pharmaceutical Inc., you can help decide the company's path forward by voting on key company decisions. Vote by tapping the link below. The deadline is May 24, 2021 11:59 PM, Eastern Time.

Votes on the table:

1. $BMRN will continue to plummet without any news regarding hemophilia unless it’s bad.

All in favor?
I!
Ok, done deal
Refreshments are in the back

GoldenEye25, published April 14, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.627 seconds.